During the past decade, Cancer Center Oncology Medical Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Center Oncology Medical Group" #1 sponsor was "Pfizer" with 4 trials, followed by "Dendreon" with 2 trials sponsored, "Active Biotech AB" with 1 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored and "Telik" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Center Oncology Medical Group" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator and "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Center Oncology Medical Group" are "Prostate Cancer" (2 trials), "Advanced Prostate Cancer" (1 trials), "Blood Clot" (1 trials), "Cancer" (1 trials) and "Castration-Resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Cancer Center Oncology Medical Group" in a lesser frequency.

Most popular intervention types in "Cancer Center Oncology Medical Group" are "Drug" (8 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Enzalutamide" (2 trials), "sipuleucel-T" (2 trials), "ABR-215050, tasquinimod" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Center Oncology Medical Group" are 6 trials for "Male" genders, 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Center Oncology Medical Group". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Cancer Center Oncology Medical Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Center Oncology Medical Group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".